Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

27/08/2014
NSWP publishes two new briefing papers on male and trans sex work

Male and Trans sex workers as a group have different experiences as sex workers than female sex workers. While male and trans sex workers make up a growing minority of sex workers, they face multiple levels of stigma and discrimination. Various laws exist around the world that criminalises same-sex relationships and cross-dressing for example. These are two types of legislation that affect...

Read more...

Tags: Advocacy




27/08/2014
European Commission approves Bristol-Myers Squibb’s Daklinza (daclatasvir) across multiple genotypes for the treatment of chronic hepatitis C infection

Daklinza, when used in combination with sofosbuvir, is an all-oral, once daily regimen yields cure rates of up to 100% Daklinza + sofosbuvir offers potential cure for a broad range of EU HCV patients, including those with advanced liver disease, genotype 3 and protease inhibitor failures Read the press release here....

Read more...





26/08/2014
MSF letter to Indian government - IP negotiations in the Regional Comprehensive Economic Partnership

head of the RCEP Ministerial Conference to be held in Myanmar on 27-28 August 2014, see letter from Medecins Sans Frontieres addressed to the Indian Minister of State for Commerce & Industry regarding the inclusion of intellectual property (IP) in the negotiations of the Regional Comprehensive Economic Partnership (RCEP) and its potential impact on access to affordable generic medicines...

Read more...





26/08/2014
FDA: Labeling update for Intelence (etravirine)

On August 20, 2014, the Intelence (etravirine) label was updated to include information regarding coadministration of etravirine with the following drugs: dolutegravir, dolutegravir/darunavir/ritonavir, dolutegravir/lopinavir/ritonavir atazanavir/ritonavir boceprevir   Read the full information here.

Read more...

Source Source: FDA





26/08/2014
How does PrEP affect fertility and pregnancy outcomes?

Taking PrEP (pre-exposure prophylaxis) does not negatively impact fertility among HIV-negative men or subsequent pregnancy outcomes among their HIV-positive female partners, suggests a new study published in the journal AIDS . Limited data are available on the effect of antiretrovirals on sperm health and male fertility, even though PrEP for the HIV-negative partner is common among...

Read more...

Source Source: The Body PRO

Tags: PrEP